{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T13:55:44Z","timestamp":1769262944318,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,22]]},"DOI":"10.7759\/cureus.102121","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:50:37Z","timestamp":1769151037000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel Galactosidase-Beta-1 Variant in Infantile GM1 Gangliosidosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Preeti","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikhar Deep","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapas","family":"Sarangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2018.03.001","article-title":"Gangliosides in axon stability and regeneration","volume":"156","author":"Lopez PH","year":"2018","unstructured":"Lopez PH, B\u00e1ez BB. Gangliosides in axon stability and regeneration. Prog Mol Biol Transl Sci. 2018, 156:383-412. 10.1016\/bs.pmbts.2018.03.001","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-17-79","article-title":"Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity","volume":"17","author":"Yang CF","year":"2010","unstructured":"Yang CF, Wu JY, Tsai FJ. Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity. J Biomed Sci. 2010, 17:79. 10.1186\/1423-0127-17-79","journal-title":"J Biomed Sci"},{"key":"ref3","article-title":"GLB1-related disorders","author":"Regier DS","year":"2021","unstructured":"Regier DS, Tifft CJ, Rothermel CE. GLB1-related disorders. GeneReviews\u00ae. Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (ed): University of Washington, Seattle, WA; 2021."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.08.016","article-title":"The clinical and molecular spectrum of GM1 gangliosidosis","volume":"215","author":"Arash-Kaps L","year":"2019","unstructured":"Arash-Kaps L, Komlosi K, Seegr\u00e4ber M, et al.. The clinical and molecular spectrum of GM1 gangliosidosis. J Pediatr. 2019, 215:152-7.e3. 10.1016\/j.jpeds.2019.08.016","journal-title":"J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13272","article-title":"Atypical mongolian spots as the initial manifestation of a lysosomal storage disorder","volume":"61","author":"Demirel \u00d6\u011f\u00fct N","year":"2020","unstructured":"Demirel \u00d6\u011f\u00fct N, Akdo\u011fan N, Ate\u015f \u00d6zdemir D, Ak\u0131n M\u015e, Is\u0131yel E, Ersoy Evans S. Atypical mongolian spots as the initial manifestation of a lysosomal storage disorder. Australas J Dermatol. 2020, 61:e371-3. 10.1111\/ajd.13272","journal-title":"Australas J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.11.009","article-title":"Extensive Mongolian spots and lysosomal storage diseases","volume":"170","author":"Mimouni-Bloch A","year":"2016","unstructured":"Mimouni-Bloch A, Finezilber Y, Rothschild M, Raas-Rothschild A. Extensive Mongolian spots and lysosomal storage diseases. J Pediatr. 2016, 170:333-e1. 10.1016\/j.jpeds.2015.11.009","journal-title":"J Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00674-1","article-title":"Systematic review of genetic substrate reduction therapy in lysosomal storage diseases: opportunities, challenges and delivery systems","volume":"38","author":"Beraza-Millor M","year":"2024","unstructured":"Beraza-Millor M, Rodr\u00edguez-Castej\u00f3n J, Del Pozo-Rodr\u00edguez A, Rodr\u00edguez-Gasc\u00f3n A, Solin\u00eds M\u00c1. Systematic review of genetic substrate reduction therapy in lysosomal storage diseases: opportunities, challenges and delivery systems. BioDrugs. 2024, 38:657-80. 10.1007\/s40259-024-00674-1","journal-title":"BioDrugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/tcr.202100269","article-title":"Pharmacological chaperones for \u03b2-galactosidase related to G(M1) -gangliosidosis and Morquio B: recent advances","volume":"21","author":"St\u00fctz AE","year":"2021","unstructured":"St\u00fctz AE, Thonhofer M, Weber P, Wolfsgruber A, Wrodnigg TM. Pharmacological chaperones for \u03b2-galactosidase related to G(M1) -gangliosidosis and Morquio B: recent advances. Chem Rec. 2021, 21:2980-9. 10.1002\/tcr.202100269","journal-title":"Chem Rec"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2015.02.28","article-title":"Gene therapy for GM1 gangliosidosis: challenges of translational medicine","volume":"3","author":"Hayward C","year":"2015","unstructured":"Hayward C, Patel HC, Manohar SG, Lyon AR. Gene therapy for GM1 gangliosidosis: challenges of translational medicine. Ann Transl Med. 2015, 3:S28. 10.3978\/j.issn.2305-5839.2015.02.28","journal-title":"Ann Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0089-7","article-title":"Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis","volume":"28","author":"Shield JP","year":"2005","unstructured":"Shield JP, Stone J, Steward CG. Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis. J Inherit Metab Dis. 2005, 28:797-8. 10.1007\/s10545-005-0089-7","journal-title":"J Inherit Metab Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455940-novel-galactosidase-beta-1-variant-in-infantile-gm1-gangliosidosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:50:38Z","timestamp":1769151038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455940-novel-galactosidase-beta-1-variant-in-infantile-gm1-gangliosidosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.102121","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}